Evoke Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,708
Closed -$553K 741
2025
Q4
$553K Buy
5,708
+531
+10% +$51.6K 0.01% 370
2025
Q3
$497K Buy
5,177
+1,618
+45% +$149K 0.01% 360
2025
Q2
$313K Buy
3,559
+316
+10% +$26.8K 0.01% 447
2025
Q1
$294K Sell
3,243
-1,038
-24% -$92.9K 0.01% 360
2024
Q4
$345K Buy
+4,281
New +$371K 0.01% 317
2023
Q3
Sell
-2,511
Closed -$223K 391
2023
Q2
$223K Buy
+2,511
New +$216K 0.01% 324
2023
Q1
Sell
-3,512
Closed -$275K 366
2022
Q4
$275K Sell
3,512
-55,000
-94% -$4.46M 0.01% 294
2022
Q3
$4.76M Sell
58,512
-3,971
-6% -$357K 0.19% 56
2022
Q2
$5.65M Sell
62,483
-17,849
-22% -$1.81M 0.21% 56
2022
Q1
$8.96M Sell
80,332
-32,397
-29% -$3.42M 0.29% 44
2021
Q4
$11.7M Buy
112,729
+18,821
+20% +$2.18M 0.37% 36
2021
Q3
$11.8M Sell
93,908
-1,276
-1% -$165K 0.44% 30
2021
Q2
$11.9M Buy
95,184
+53
+0.1% +$6.66K 0.45% 32
2021
Q1
$11.3M Buy
95,131
+94,335
+11,851% +$11.1M 0.51% 27
2020
Q4
$94K Sell
796
-463
-37% -$51K 0.01% 305
2020
Q3
$132K Sell
1,259
-20
-2% -$2.01K 0.01% 252
2020
Q2
$118K Sell
1,279
-11
-0.9% -$1.05K 0.01% 253
2020
Q1
$117K Sell
1,290
-1,646
-56% -$175K 0.02% 239
2019
Q4
$335K Sell
2,936
-1,624
-36% -$178K 0.04% 160
2019
Q3
$498K Buy
+4,560
New +$476K 0.06% 147

Other funds holding MDT

Evoke Wealth's MDT Position: Q1 2026 in Review

Evoke Wealth sold out of Medtronic (MDT) in Q1 2026, closing a stake of 5,708 shares — an estimated $553K sold.

Evoke Wealth first reported a position in MDT in Q3 2019 and held it in 20 quarters. The position peaked at $11.9M in Q2 2021. 2,244 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Evoke Wealth reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Evoke Wealth sold 5,708 Medtronic shares in Q1 2026, an estimated $553K.
  • Evoke Wealth first reported a position in Medtronic in Q3 2019 and held it in 20 quarters.
  • Evoke Wealth's Medtronic position peaked at $11.9M in Q2 2021.
  • 2,244 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Evoke Wealth's 13F filing for Q1 2026, filed 15 May 2026.